Keeping Current podcast

Refining Adjuvant Therapy in HR-Positive/HER2-Negative Early Breast Cancer: Personalizing Care in the CDK4/6 Inhibitor Era

24/09/2026
0:00
52:10
Reculer de 15 secondes
Avancer de 15 secondes

How can adjuvant therapy be optimally individualized? What tools and insights are required? Join us to learn more.

Credit available for this activity expires: 09/21/2027 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/refining-adjuvant-therapy-hr-positive-her2-negative-early-2026a1000ysl?ecd=bdc_podcast_libsyn_mscpedu


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

D'autres épisodes de "Keeping Current"